Kanagawa, Japan

Hajime Miyamoto

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 279(Granted Patents)


Location History:

  • Miyagi, JP (2000)
  • Shizuoka, JP (2011)
  • Kanagawa, JP (1996 - 2016)

Company Filing History:


Years Active: 1996-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Hajime Miyamoto: Innovator in Antibody Development

Introduction

Hajime Miyamoto is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of anti-AXL antibodies. With a total of 7 patents to his name, his work has the potential to impact cancer treatment and diagnostics.

Latest Patents

Miyamoto's latest patents include innovative approaches to humanizing mouse-derived anti-AXL antibodies. The objective of this invention is to decrease the immunogenicity of these antibodies in humans. The antibodies developed can bind to a specific region in Anexelekto (AXL) and are produced based on humanized versions of these antibodies. These anti-AXL antibodies exhibit high antitumor activity and are useful as agents for decreasing AXL expression levels, serving as antitumor agents and diagnostic tools for cancer. Another notable patent involves a monoclonal antibody capable of binding to Anexelekto, which has shown angiogenesis-suppressive effects and antitumor properties. This invention highlights the potential of these antibodies as angiogenesis inhibitors and agents for modulating phosphorylation activity.

Career Highlights

Throughout his career, Hajime Miyamoto has worked with notable companies such as Fuji Photo Film Company, Limited and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in antibody development and biotechnology.

Collaborations

Miyamoto has collaborated with esteemed colleagues, including Yoshio Idota and Akihiro Matsufuji. These partnerships have fostered innovation and advancement in his research endeavors.

Conclusion

Hajime Miyamoto's contributions to the field of biotechnology, particularly in the development of anti-AXL antibodies, demonstrate his commitment to advancing cancer treatment. His innovative patents and collaborations highlight the importance of teamwork in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…